Press Releases

Hogan Lovells advises Osiris in US$660 million acquisition by Smith & Nephew

Washington, D.C., 13 March 2019 – International law firm Hogan Lovells has advised Osiris Therapeutics, Inc., (NASDAQ: OSIR), a developer of regenerative medicine products, in an...

Press Releases

Hogan Lovells examines innovation and challenges in the life sciences and health care industries with second annual report

Washington, D.C.,12 March 2019 – Global law firm Hogan Lovells today published Life Sciences and Health Care Horizons, the firm’s second annual insight into current and...

Media Mention

Too early to conclude on Hong Kong's attractiveness as biotech IPO destination

Stephen Peepels spoke to the South China Morning Post on the attractiveness of Hong Kong as a biotech IPO destination under the new listing rules.

Published Works

The controversy over gene-editing

Press Releases

Hogan Lovells rings in the New Year with 30 promotions to partner and 47 promotions to counsel

LONDON and WASHINGTON, D.C., 3 January 2019 – Global law firm Hogan Lovells today announced that 30 of its people have been promoted to partner effective 1 January across its global...

Press Releases

Media briefing note Controversy over gene editing comment Hogan Lovells as Chinese research greeted with consternation

Shortly before the start of the second international summit on human genome editing in Hong Kong this week, it was announced that Chinese researcher, He Jiankui, had successfully used a...

Press Releases

Hogan Lovells advises Valneva in its €50 million fundraising

Hogan Lovells has advised Valneva in its €50 million fundraising of gross proceeds in a private placement of its ordinary shares.

Loading data